US Patent 7323168 Immunotherapy for chronic myelocytic leukemia
Patent 7323168 was granted and assigned to IMMUNOMEDICS, INC. on January, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 26, 2004
Date of Patent
January 29, 2008
Patent Application Number
10853150
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7323168 Immunotherapy for chronic myelocytic leukemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
